Dobutamine In Dextrose
NADAC/unit
N/A
Active Shortage
Active Shortages
2017-11-06 Next Delivery: April 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company
2017-11-06 Next Delivery: April 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company
2017-11-06 Next Delivery: April 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
